-
Metformin has a new effect
Time of Update: 2020-09-03
18, or can reduce adverse glucosticogen reactions Recently, The Lancet - Diabetes and Endocrinology published a study - the results of a phase 2 clinical trial, metformin for patients with chronic inflammatory diseases, can improve metabolic health, reduce the serious side effects of glucosin therapy.
-
What does it mean to find a new strain of the corona virus in multiple countries?
Time of Update: 2020-09-02
take the four cases of D614G mutant strains found in Malaysia as an example, as early as early July, a study in the journal Cell discussed the D614G variant, a new coronary virus variant caused by amino acid changes.
-
Chinese scholars reveal the characteristics of adaptive immune response to new coronary pneumonia.
Time of Update: 2020-09-01
this study is important for understanding the pathogenesis and rehabilitation mechanisms of patients with severe and mild coronary pneumonia, as well as for the design of vaccines and therapeutic drugs to combat SARS-CoV-2 infections.
-
"Yinchuan City SLOW disease management - slow lung patients digital management project" officially launched.
Time of Update: 2020-08-31
Guide: To help the construction of "Internet plus medical health" and explore the innovative management mode of slow-impedance lung. , Aug. 18, 2020 /USC/ -- On August 18, 2020, the Yinchuan City Heal
-
Three NMOSD drugs approved by the FDA in one year! Roche/Genetek deepens the drug layout of neurological disorders.
Time of Update: 2020-08-31
recently, the FDA approved Roche's Gene Tektronumab's Enspryng (satralizumab) for the treatment of adult patients with anti-water channel protein-4 (AQP4) antibody-positive optic neuromyelitis spectrum disorder (NMOSD).
June, Viela Bio's anti-CD19 monoantimmune drug Uplizna (formerly KNOWNI-551) was approved by the U.S. FDA to treat NMOSD-positive adult patients with anti-AQP4 antibodies.
-
The strain mutates, the more it recovers, and the new corona virus becomes more dangerous?
Time of Update: 2020-08-31
, chief infectious disease specialist at Russia's Health Ministry, said there was no scientific data on how long antibodies could last in people infected with the new crown and how many were produced depending on the severity of the disease.
-
Blinger Ingehan is involved in the European New Crown Acceleration Research and Development Project, focusing on the development of new crown virus-specific antibodies.
Time of Update: 2020-08-31
Guide: With the support of the European Alliance for Innovative Drugs (IMI), CARE (European New Crown Accelerated Research and Development) is scheduled to be launched today to accelerate the discover
-
And Platinum Pharma and its partners announced a partnership with Kidis Pharma to develop monoclonal antibodies, natural killer cell therapy COVID-19.
Time of Update: 2020-08-30
CAMBRIDGE, Mass., Rotterdam, Netherlands, and Suzhou, China August 19, 2020 /USC/-- AND PLATINUM Pharmaceuticals (HBM) and its partners Utrecht University, Erasmus Medical Center and Viviclinics-DDL announced today that they are working with Kidis Pharma (Amsterdam and Brussels Euron european stock exchanges) KDS) collaborated on a joint therapy for antibody (mAb) and natural killer (NK) cells, which will further expand and platinum medicine's research in the field of new coronavirus (SARS-CoV-2) antibodies for the treatment of new coronavirus pneumonia (COVID-19).
-
Failure of special parts of the powder filler? No panic, you can do it yourself.
Time of Update: 2020-08-29
industry pointed out that today's powder fillers in many industries can be said to be very simple to use, but whether semi-automatic or fully automatic, with a long time will inevitably appear some problems, especially for some customers who do not understand the machine, it will often be confused in the face of failure.
-
Tumor virus therapy again received attention to pharmaceutical companies, start-up active plus code.
Time of Update: 2020-08-17
in addition, there are many pharmaceutical companies choose to independently develop anti-tumor virus immunotherapy drugs, including 3D biology, Tiandakang gene, Dabo Bio, Kanghong Biology, Yino Micromedicine, Binhebio, Renohealthy Bio, Lepu Biology and so on.
-
July 4 innovative drugs to "China's speed" to run out of the world synchronous innovation drug.
Time of Update: 2020-08-16
Figure 5: Global Anti-HIV Drug Development Phase (partial) Source: Inqovi, a global drug research and development bank for Mitanet, july 7, FDA approved the listing of Inqovi (Disita-sized-cedazuridine), a subsidiary of Otsuka Pharmaceuticals, for the treatment of myelal hyperplasia syndrome and chronic monocytomyleukemia patients.
-
Bayer achieved revenue of 22.9 billion euros in the first half of the year, and its business in China was affected by the volume of purchases!
Time of Update: 2020-08-14
crop science business continued to perform strongly in the second quarter, with sales of the pharmaceutical and consumer health businesses declining, mainly due to the GLOBAL OUTBREAK OF COVID-19 and China's Volume Purchasing Policy.
-
How far is the drug for Parkinson's disease when the condition improves after stem cell treatment?
Time of Update: 2020-08-14
four studies focused on the activity of the GBA gene product glucose encephalosomes, which are closely related to lysozyme function, including two new trials of the old drug ampichimino, Sanofi's venglustat, and Prevail Therapeutics gene therapy.
(2020) Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020.
-
100 million doses of the new crown test vaccine! Johnson and Johnson reached an agreement with the U.S. government.
Time of Update: 2020-08-14
Johnson and Johnson announced today that its Johnson and Johnson Pharmaceuticals has reached an agreement with the U.S. government to mass produce and supply 100 million doses of Jansen's new generic virus experimental vaccine, Ad26.COV2, in the United States.
-
Colleen, Yang Zijiang... Grab the first imitation! Mercayton's $1 billion injection again greets the troublemakers.
Time of Update: 2020-08-13
before this, Shu more glucose sodium injection has been Hunan Collum Pharmaceuticals, Yangzijiang Pharmaceuticals, Nanjing Zhengda Tianqing and other 12 enterprises submitted listing applications, and are copied 4 categories of declaration, after approval will be treated as if through the consistency evaluation.
-
In the United States biological-like drug "golden age" Pfizer, Amgen will make a big profit!
Time of Update: 2020-08-13
at Pfizer's second-quarter 2020 earnings conference call last week, analysts turned more attention to the company's potential future returns from research and development of the new generic vaccine, to the extent that biosimilars, which are currently the revenue business area, were overlooked.
-
"Wangxing man" olfactory detection of new coronavirus patients, accuracy rate of up to 94%
Time of Update: 2020-08-13
A recent study published in BMC Infectious Diseases by researchers from the University of Veterinary Medicine in Hanover, Germany, and the German Defence Force confirmed that this is possible: Trained detection dogs can distinguish between patients infected with sars-CoV-2 infection and uninfected people by identifying respiratory secretions.
-
The results of Sindilla's first-line treatment of non-squamous non-small cell lung cancer were published.
Time of Update: 2020-08-13
ORIENT-11 is a randomized, double-blind, Phase III controlled clinical study that compares the ® of Dabersu (Cindilly monobify injection) or the placebo combined libbite ® (injection of pemequal dissin) and platinum for advanced or recurrent non-scaly small cell lung cancer treatment without EGFR sensitivity mutations or ALK gene rearrangements.
-
Beda Pharmaceuticals: Analysis results in the middle of the study period of nsatini hydrochloric acid eXalt3.
Time of Update: 2020-08-13
Guide: The results showed that in patients with ALK-positive non-small cell lung cancer (NSCLC) treated with Ensatinib, the no-progression survival (mPFS) was significantly longer than in patients treated with cratinib.
results showed that alK-positive non-small cell lung cancer (NSCLC) patients treated with Ensatinib had significantly longer progression-free survival (mPFS) than those treated with cratinib.
-
Cholesterol from diet and phytosterols are directly linked to heart disease.
Time of Update: 2020-08-12
studies have shown that people with sequence variationthat that reduce the function of ABCG5/8 transport proteins have an increase in blood cholesterol and phytosterol levels, as well as the risk of heart disease.
